ClearanceBrief
Recall Z-0727-2025 ยท MMI Immunoassay Method, Troponin Subunit

Beckman Coulter, Inc.

Access hsTnI Reagent, REF B52699, Immunoassay Method, Troponin Subunit. For the quantitative determination of cardiac troponin I (cTnI) levels in human serum and plasma.

DateDec 20, 2024 (initiated Nov 18, 2024)
StatusOpen, Classified
ReasonBeckman Coulter, Inc. is recalling their Access hsTnI assay, a medical device by correction. The reason for the recall is: high troponin antigen (>55,000 pg/mL) can contaminate an analyzers probe and cause inter-assay carryover due to insufficient washing. The contamination can cause a falsely elevated Access hsTnI result in subsequent sample(s) which can impact patient care (potentially but not limited to unnecessary coronary imaging or diagnostic catheterization) if the result is near the medical decision points.
Root causeComponent design/selection
ActionBeckman Coulter issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 11/18/2024 via USPS and email. The notice explained the issue, impact to patient care, and requested the following actions be taken: " - Follow your established laboratory protocols for analyzing and retesting discrepant samples if an observed Access hsTnI test result does not align with the patient s clinical presentation. - Beckman Coulter recommends reviewing the content of this letter with your laboratory and/or medical director to determine appropriate next steps. Please share this information with your
Quantity2,109,804 units
DistributionWorldwide
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K121214ACCESS ACCUTNI+3 REAGENT AND ACCESS ACCUTN1+3 CALIBRATORS FOR USE ON THE ACCESS 2 IMMUNOASSAY SYSTEM
Beckman Coulter, Inc., Jun 14, 2013
K172783Access hs Tnl
Beckman Coulter, Inc., Jun 12, 2018
K222881Access hsTnI
Beckman Coulter, Inc., Dec 18, 2023
K230648Access hsTnI
Beckman Coulter, Inc., Dec 4, 2023